• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Disseminated cryptococcosis presenting with generalized cutaneous involvement in a rheumatoid arthritis patient receiving tofacitinib: A case report.

作者信息

Li Zonghui, Shan Yuxin, Dong Jiazheng, Mei Huan, Kong Qingtao, Li Yan

机构信息

Department of Dermatology, The First Affiliated Hospital of Soochow University, Suzhou, China.

School of Medicine, Southeast University, Nanjing, China.

出版信息

J Dermatol. 2024 Feb;51(2):e39-e41. doi: 10.1111/1346-8138.16960. Epub 2023 Sep 12.

DOI:10.1111/1346-8138.16960
PMID:37698047
Abstract
摘要

相似文献

1
Disseminated cryptococcosis presenting with generalized cutaneous involvement in a rheumatoid arthritis patient receiving tofacitinib: A case report.在接受托法替布治疗的类风湿关节炎患者中出现全身皮肤受累的播散性隐球菌病：一例报告。
J Dermatol. 2024 Feb;51(2):e39-e41. doi: 10.1111/1346-8138.16960. Epub 2023 Sep 12.
2
Summaries for patients: tofacitinib for the treatment of rheumatoid arthritis.患者摘要：托法替布用于治疗类风湿关节炎。
Ann Intern Med. 2013 Aug 20;159(4):I-26. doi: 10.7326/0003-4819-159-4-201308200-00002.
3
IgA Vasculitis Developed as an Adverse Effect of Tofacitinib Taken for Rheumatoid Arthritis.IgA血管炎作为类风湿关节炎患者服用托法替布的不良反应而发生。
Intern Med. 2020 Mar 15;59(6):817-821. doi: 10.2169/internalmedicine.3668-19. Epub 2019 Dec 6.
4
Reversible eruption of neurofibromatosis associated with tofacitinib therapy for rheumatoid arthritis.与托法替布治疗类风湿关节炎相关的神经纤维瘤病可逆性皮疹。
Rheumatology (Oxford). 2019 Jun 1;58(6):1111-1113. doi: 10.1093/rheumatology/kez012.
5
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial.托法替布单药治疗、托法替布联合甲氨蝶呤与阿达木单抗联合甲氨蝶呤治疗类风湿关节炎患者的疗效和安全性（ORAL Strategy）：一项 IIIb/IV 期、双盲、头对头、随机对照临床试验。
Lancet. 2017 Jul 29;390(10093):457-468. doi: 10.1016/S0140-6736(17)31618-5. Epub 2017 Jun 16.
6
A pooled analysis of the safety of tofacitinib as monotherapy or in combination with background conventional synthetic disease-modifying antirheumatic drugs in a Phase 3 rheumatoid arthritis population.一项托法替布作为单药或与背景下的常规合成疾病修饰抗风湿药物联合治疗 3 期类风湿关节炎人群的安全性的汇总分析。
Semin Arthritis Rheum. 2018 Dec;48(3):406-415. doi: 10.1016/j.semarthrit.2018.07.006. Epub 2018 Jul 19.
7
Herpes zoster and tofacitinib therapy in patients with rheumatoid arthritis.带状疱疹和托法替尼治疗类风湿关节炎患者。
Arthritis Rheumatol. 2014 Oct;66(10):2675-84. doi: 10.1002/art.38745.
8
[Relevance of involvement of tofacitinib in T cell subsets to clinical courses and adverse events in patients with rheumatoid arthritis].托法替布作用于T细胞亚群与类风湿关节炎患者临床病程及不良事件的相关性
Nihon Rinsho Meneki Gakkai Kaishi. 2015;38(6):443-7. doi: 10.2177/jsci.38.443.
9
FDA approves tofacitinib for rheumatoid arthritis.美国食品药品监督管理局批准托法替布用于治疗类风湿关节炎。
Am J Health Syst Pharm. 2012 Dec 15;69(24):2120. doi: 10.2146/news120088.
10
Tofacitinib in Combination With Conventional Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis: Patient-Reported Outcomes From a Phase III Randomized Controlled Trial.托法替布联合传统改善病情抗风湿药物治疗活动性类风湿关节炎患者：一项III期随机对照试验的患者报告结局
Arthritis Care Res (Hoboken). 2017 Apr;69(4):592-598. doi: 10.1002/acr.23004.

引用本文的文献

1
Cryptococcosis in a patient with rheumatoid arthritis following glucocorticoid and JAK inhibitor therapy: a case description on stabilization with tocilizumab.类风湿关节炎患者在接受糖皮质激素和JAK抑制剂治疗后发生隐球菌病：一例使用托珠单抗实现病情稳定的病例描述
Quant Imaging Med Surg. 2025 Apr 1;15(4):3738-3742. doi: 10.21037/qims-24-1825. Epub 2025 Mar 28.
2
Cryptococcosis Associated With Biologic Therapy: A Narrative Review.生物治疗相关的隐球菌病：一篇叙述性综述。
Open Forum Infect Dis. 2024 Jun 26;11(7):ofae316. doi: 10.1093/ofid/ofae316. eCollection 2024 Jul.